258 filings
Page 8 of 13
8-K
sch d2eck
8 May 17
Acceleron Pharma Reports First Quarter 2017 Operational and Financial Results
12:00am
8-K
bvgm1m77p4g 85nrl6
2 May 17
Departure of Directors or Certain Officers
12:00am
8-K
hw4wd6q
27 Apr 17
Acceleron Provides Clinical Development Updates on Luspatercept Program
12:00am
DEFA14A
2641fbqq2mixzryqpm6i
13 Apr 17
Additional proxy soliciting materials
12:00am
CT ORDER
ix6mryu4
22 Mar 17
Confidential treatment order
12:00am
8-K
dhscs ympf1px
1 Mar 17
Acceleron Reports Fourth Quarter and Year Ended 2016 Operational and Financial Results
12:00am
8-K
9hs 7dti6r8yjfbfh9q
9 Jan 17
Regulation FD Disclosure
12:00am
8-K
8nn 6pro10c4ateylc7w
7 Dec 16
Other Events
12:00am
8-K
gd19g6k
3 Nov 16
Acceleron Pharma Reports Third Quarter 2016 Financial and Operational Results
12:00am
8-K
b6uwhre2q7kkrcai 0i
27 Sep 16
Departure of Directors or Certain Officers
12:00am
8-K
eeqfrdbo n82
12 Sep 16
Amendments to Articles of Incorporation or Bylaws
12:00am
CT ORDER
u8795
8 Aug 16
Confidential treatment order
12:00am
8-K
6jki31 b1cpalsfh
4 Aug 16
Acceleron Pharma Reports Second Quarter 2016 Financial and Operational Results
12:00am
8-K
mz6c1sie0qd7elhz3g
25 Jul 16
Departure of Directors or Certain Officers
12:00am
8-K
wy0 pnqtbe
11 Jul 16
Acceleron Announces ACE-083 Phase 1 Results at the 14th International Congress on Neuromuscular Diseases
12:00am